1: The Life Cycle of Fasciola hepatica, S J Andrews, Schering-Plough Animal Health, Uxbridge, UK 2: Development of Fasciola hepatica in the Intermediate Host, T K Graczyk, John Hopkins University, Baltimore, USA and B Fried, Lafayette College, Easton, USA 3: Development of Fasciola hepatica in the Mammalian Host, I Fairweather, The Queen's University of Belfast, Northern Ireland, et al. 4: Epidemiology and Control, P Torgerson, University College, Dublin, Republic of Ireland, and J Claxton, University of Liverpool, UK 5: Predicting Outbreaks of Fasciolosis: From Ollerenshaw to Satellites, J B Malone, Louisiana State University, USA and J M Yilma, Addis Ababa University, Ethiopia 6: Pathology, Pathophysiology and Clinical Aspects, C A Behm, The Australian National University, Australia and N C Sangster, University of Sydney, Australia 7: Mechanisms of Fasciolicide Action and Drug Resistance in Fasciola hepatica, I Fairweather and J C Boray, Elizabeth Macarthur Agricultural Institute, NSW, Australia 8: Metabolism, A G M Tielens, Utrecht University, The Netherlands 9: Neurobiology, D W Halton, The Queen's University of Belfast, Northern Ireland, et al. 10: Immunology of Fasciola hepatica Infection, G Mulcahy, University College Dublin, Republic of Ireland, et al. 11: Development of Vaccines Against Fasciola hepatica, T W Spithill, Monash University, Clayton, Australia, et al. 12: Human Fasciolosis, S Mas-Coma, Universidad de Valencia, Spain, et al. 13: Immunodiagnosis of Human and Animal Fasciolosis, G V Hillyer, University of Puerto Rico, Suan Juan, USA 14: Molecular Biology, M Panaccio, Nomura/JAFCO Investments (Asia) Ltd., Melbourne, Australia and A Trudgett, The Queen's University of Belfast, Northern Ireland 15: Fasciola gigantica: Epidemiology, Control, Immunology and Molecular Biology, T W Spithill, Monash University, Clayton, Australia, et al.
